Tmunity Stock

tmunity.comHealthcare / BioTech & PharmaFounded: 2015Funding to Date: $292.52MM

Tmunity is a clinical-stage biotherapeutics company focused on saving and improving lives by delivering the full potential of next-generation T-cell immunotherapy to patients with devastating diseases.

Register To Buy and Sell Shares

For more details on financing and valuation for Tmunity, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access Tmunity’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Tmunity.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.


Management Team

Graeme Bell
Chief Financial Officer & Executive Vice President
Michael Christiano
Executive Vice President and Chief Business Officer
Bruce Levine Ph.D
Co-Founder & Advisor
Usman Azam MD
President, Chief Executive Officer & Board Member
Christina Coughlin MD
Chief Medical Officer & Executive Vice President
Bruce Blazar MD
Co-Founder & Advisor
Yangbing Zhao Ph.D
Co-Founder & Advisor
Anne Chew Ph.D
Co-Founder, Advisor & Board Member
Jason Krentz
Chief Technology Officer & Head, Technical Operations
James Riley
Co-Founder & Advisor
Carl June MD
Co-Founder & Chief Scientific Advisor

Board Members

Patrick Gray
Anne Chew Ph.D
Usman Azam MD
Garry Nicholson

News Highlights

Tmunity Secures $75M in Series B Financing | FinSMEs
Tmunity Therapeutics, a Philadelphia, PA-based T-cell immunotherapy company, closed a $75m Series B financing. The round was led by Andreessen Horowitz
Tmunity Therapeutics Raises $100 Million in Series A Financing to Advance Portfolio of Next-Generation T cell Immunotherapies to Transform the Treatment of Cancer
Tmunity Therapeutics, Inc., a private clinical-stage biotherapeutics company focused on saving and improving lives by delivering the full potential of
Updated on: Apr 14, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.